Updated February 23 at 6:24am
Life Sciences
78 results total, viewing 41 - 50
Dr. Rebecca M. Reece joined University Medicine’s Division of Infectious Diseases in January 2015. Her clinical and research interests include tick-borne diseases, HIV adherence and retention, and health disparities. Reece talks about the risks of Zika and her role as an infectious disease specialist. more
Using sonar and other tools, researchers and University of Rhode Island students are mapping the Atlantic Ocean floor to measure changes after Hurricane Sandy. more
A recent report from CBRE, a real estate services firm, which analyzed U.S. tech employment over the past five years, listed the top 50 technology markets in the United States, but Providence was not one of them. more
The Miriam Hospital on Monday announced it has received a $2.8 million grant to study whether weight loss could prevent recurring gestational diabetes. more
The University of Rhode Island’s Watershed Watch program, now in its 29th year, is one of the longest-running citizen science projects in Rhode Island. It works with volunteers to collect data on water quality in the state’s lakes, ponds, streams and bays, and the data are used by watershed conservation organizations, policy makers, regulators and state and local officials to make decisions that improve and protect the health of local waters. more
The Brain Injury Association of Rhode Island will hold its 15th annual Statewide Brain Injury Conference, Anchoring Hope After Brain Injury, from 8 a.m.- 4 p.m., on March 18 at the Crowne Plaza Hotel, Warwick. more
Luna Pharmaceuticals Inc., maker of Premama products, has raised more than half of a $3.5 million Series B equity round, according to a federal filing, which it plans to use it to grow sales, add employees and become profitable. more
Women who’ve had breast cancer surgery often live out their lives with highly visible scars reminding them of their diagnosis and surgery. more
CVS Health Corp. announced Thursday that it would begin selling a generic substitute for the EpiPen at more than 83 percent less than the full retail price of the brand-name version of the product. more
CVS Health Corp. ranked 44th on a list of the world’s most valuable brands, according to the latest Brand Finance Global 500 report released this week. more
« Prev | 1 2 | 3 | 4 | 5 | 6 | 7 | 8 Next »